| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Income before income tax expense | 218,958 | 204,938 | 143,828 | 165,147 |
| Income tax expense | 43,733 | 39,778 | 25,733 | 28,136 |
| Net income | 175,225 | 165,160 | 118,095 | 137,011 |
| Basic (in shares) | 117,219,000 | 121,343,000 | 123,215,000 | 126,850,000 |
| Basic (usd per share) | 1.49 | 1.36 | 0.96 | 1.08 |
| Diluted (in shares) | 122,331,000 | 124,158,000 | 126,644,000 | 130,134,000 |
| Diluted (usd per share) | 1.43 | 1.33 | 0.93 | 1.05 |
HALOZYME THERAPEUTICS, INC. (HALO)
HALOZYME THERAPEUTICS, INC. (HALO)